✦ LIBER ✦

Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients

✍ Scribed by Heinrich Lellek; Dirk Waldenmaier; Joachim Dahlke; Francis Ayketang Ayuk; Christine Wolschke; Nicolaus Kröger; Axel R. Zander

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MalasseziaSpecies: A Rare Cause of Invas

✍ Charalampos Dokos; Zoi-Dorothea Pana; Athanasios Tragiannidis 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 133 KB

Efficacy and safety of caspofungin thera

✍ M. J. DiNubile; K. M. Strohmaier; R. J. Lupinacci; A. R. Meibohm; C. A. Sable; N 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 130 KB

Efficacy of caspofungin as salvage thera

✍ J. W. Hiemenz; I. I. Raad; J. A. Maertens; R. Y. Hachem; A. J. Saah; C. A. Sable 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 160 KB

Multicenter, noncomparative study of cas

✍ Johan Maertens; Axel Glasmacher; Raoul Herbrecht; Anne Thiebaut; Catherine Cordo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Epidemiology of invasive fungal infectio

✍ M. Hoenigl; I. Zollner-Schwetz; H. Sill; W. Linkesch; C. Lass-Flörl; W. J. Schne 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Cost-Effectiveness of Posaconazole versu

✍ Amy K. O'Sullivan; Ankur Pandya; George Papadopoulos; David Thompson; Amelia Lan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB